PharmaVigilant Inks Contract With Synergy Pharmaceuticals

PharmaVigilant, a clinical trial technology provider, has been selected by Synergy Pharmaceuticals Inc. to support its one-year, multi-center Phase II study focused on the development of a new drug to treat gastrointestinal disorders and diseases.
GEN